Effect of Safety Issues with HIV Drugs on the Approval Process of Other Drugs in the Same Class: An Analysis of European Public Assessment Reports

Author： Arnardottir Arna H.   Haaijer-Ruskamp Flora M.   Straus Sabine M.J.   de Graeff Pieter A.   Mol Peter G.M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.11, 2011-11, pp. : 1101-1114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-epileptic drugs in pregnancy: current safety and other issues

By Morrow James I   Craig John J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 445-456

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Cardiac Safety Assessment of Drugs

By Hanton Gilles  

Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. : 213-228

Adis International

Access to resources Recommend Favorite

Immunotoxicology: Role in the Safety Assessment of Drugs

By Jacques Descotes  

Drug Safety, Vol. 28, Iss. 2, 2005-01 ,pp. : 127-136

Adis International

Access to resources Recommend Favorite

Assessment of safety of the major antimalarial drugs

By Chattopadhyay Rana   Mahajan Babita   Kumar Sanjai  

Expert Opinion on Drug Safety, Vol. 6, Iss. 5, 2007-09 ,pp. : 505-521

Informa Healthcare

Access to resources Recommend Favorite

“Virostatics” as a Potential New Class of HIV Drugs

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4103-4120

Bentham Science Publishers

Access to resources Recommend Favorite